Boston-based Vertex Pharmaceuticals has opened a 170,000-square-foot research facility in San Diego, more than doubling the company’s footprint locally.

About 70 percent of the new site, at 3215 Merryfield Row, is dedicated to lab and research space, with a focus on the lung disease cystic fibrosis. Vertex has already discovered three cystic fibrosis medicines in San Diego.

“The new site will allow us to continue investing in science to bring more transformative medicines to people with serious diseases,” said Vertex’s David Altshuler, executive vice president, global research and chief scientific officer, in a news release.

The spot also includes a 1,500-square-foot education lab to promote technology, engineering, arts and math among students, along with a 4,000-square-foot incubator for collaboration with outside organizations.

Building construction took nearly 18 months, overseen by Alexandria Real Estate. Vertex signed a 16-year lease.

The company’s prior building was 80,000 square feet.